Edarbyclor
New Procedure May Aid Stubborn High Blood Pressure »
"Dec. 18, 2012 -- People who can't get their high blood pressure down with drugs may be helped by a new procedure that deactivates overactive nerves in the kidneys, a small study shows.
The procedure is already available in Europe and "...
Read the New Procedure May Aid Stubborn High Blood Pressure article »
Edarbyclor
OVERDOSE
Limited data are available related to overdosage in humans.
Azilsartan medoxomil
Limited data are available related to overdosage in humans. During controlled clinical trials in healthy subjects, once daily doses up to 320 mg of azilsartan medoxomil were administered for 7 days and were well tolerated. In the event of an overdose, supportive therapy should be instituted as dictated by the patient's clinical status. Azilsartan is not dialyzable.
Chlorthalidone
Symptoms of acute overdosage include nausea, weakness, dizziness, and disturbances of electrolyte balance. The oral LD50 of the drug in the mouse and the rat is more than 25,000 mg/kg body weight. The minimum lethal dose (MLD) in humans has not been established. There is no specific antidote, but gastric lavage is recommended, followed by supportive treatment. Where necessary, this may include intravenous dextrose-saline with potassium, administered with caution.
CONTRAINDICATIONS
Edarbyclor is contraindicated in patients with anuria [see WARNINGS AND PRECAUTIONS].
Do not co-administer aliskiren with Edarbyclor in patients with diabetes (4).
Last reviewed on RxList: 10/16/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Edarbyclor Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Hypertension
Get tips on handling your hypertension.
Updated & New
